An expert consensus to standardise definitions, diagnosis and treatment targets for anti‐fibrotic stricture therapies in Crohn's disease
Alimentary Pharmacology & Therapeutics2018Vol. 48(3), pp. 347–357
Citations Over TimeTop 1% of 2018 papers
Florian Rieder, Dominik Bettenworth, Christopher Ma, Claire E. Parker, Leeann Williamson, Sigrid Nelson, Gert Van Assche, Antonio Di Sabatino, Yoram Bouhnik, Ryan W. Stidham, Axel Dignaß, Gerhard Rogler, Stuart A. Taylor, Jaap Stoker, Jordi Rimola, Mark E. Baker, Joel G. Fletcher, Julián Panés, William J. Sandborn, Brian G. Feagan, Vipul Jairath
Abstract
Consensus criteria for diagnosis and response to therapy in stricturing Crohn's disease should inform both clinical practice and trial design.
Related Papers
- → The evolving management of postoperative Crohn’s disease(2012)27 cited
- → Crohn’s Is Not a 6-Week Disease(2004)29 cited
- → The many faces of Crohn’s Disease: Latest concepts in etiology(2012)10 cited
- The Effect of Smoking on the Crohn's Disease(2006)
- → Effective nursing care for Crohn's disease during pregnancy based on pharmacological treatments.(2023)